RESPONSE-HIT

USPTO USPTO 2000 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark RESPONSE-HIT was filed as Word mark on 08/23/2000 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 12/31/2002. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: August 21, 2019

Trademark form Word mark
File reference 78022510
Register number 2669123
Application date August 23, 2000
Publication date October 8, 2002
Entry date December 31, 2002

Trademark owner

65 Boulevard Massena
75013 Paris
FR

Trademark representatives

goods and services

5 Nucleic acid arrays on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases; chemical reagents for medical use
9 Computer programs for medical testing, to analyze nucleic acids present in human or animal cells, using nucleic acid arrays on filters or chips and chemical reagents, to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
10 Nucleic acid probes on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
42 Medical testing services for analysis of nucleic acids found in human or animal cells to determine the presence of pathologies, namely, cancer and neurodegenerative diseases, or the effect of drugs on such pathologies, namely, cancer and neurodegenerative diseases

ID: 1378022510